Valneva announces launch of proposed global offering of american depository shares and ordinary shares

Saint herblain ( france), october 2 6 , 202 1 – valneva se (nasdaq: valn; euronext paris: vla) (the “company”), a specialty vaccine company, today announced its intention to issue and sell, subject to market conditions, 5,500,000 of its ordinary shares in a global offering to specified categories of investors comprised of (i) a public offering of its american depositary shares (“adss”), each representing two ordinary shares, in the united states (the “u.s. offering”) and (ii) a concurrent private placement of its ordinary shares in certain jurisdictions outside of the united states (the “european private placement” and together with the u.s. offering, the “global offering”).
VALN Ratings Summary
VALN Quant Ranking